Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Avalo Therapeutics Q3 Earnings

Avalo Therapeutics (NASDAQ:AVTX) reported its Q3 earnings results on Monday, November 7, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
November 7, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Avalo Therapeutics (NASDAQ:AVTX) reported its Q3 earnings results on Monday, November 7, 2022 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Avalo Therapeutics beat estimated earnings by 131.19%, reporting an EPS of $0.34 versus an estimate of $-1.09.

Revenue was up $13.60 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.39 which was followed by a 1.85% drop in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Avalo Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For TrueBlue

By Benzinga Insights
July 22, 11:21 AM
TrueBlue (NYSE:TBI) is set to give its latest quarterly earnings report on Monday, 2022-07-25. Here's what investors need to know before the announcement. Analysts estimate that TrueBlue will report an earnings per share (EPS) of $0.53.

TBI